Author

Fu-Yen Chang

Fred Hutch Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Anthony RongvauxiD· 1 shared Axia SongiD· 1 shared Derek L. StirewaltiD· 1 shared Elizabeth A. BonneriD· 1 shared Erica A. Arriaga-GomeziD· 1 shared Ettaib El MarabtiiD· 1 shared Jacob AppelbaumiD· 1 shared Jahan A. RahmaniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anthony RongvauxORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Somatic DDX41 mutations confer neomorphic splicing activity in the pathogenesis of myelodysplastic neoplasms

Rasika Venkataraman, Noemi Puccio, Tun‐Yun Hsueh, Elizabeth A. Bonner, Fu-Yen Chang, Erica A. Arriaga-Gomez, Axia Song, Takero Miyagawa, Jahan A. Rahman, Oluwanifemi Akinwande, Sayantani Sinha, Ettaib El Marabti, Robert S. Welner, Rui Lu, Paul Brent Ferrell, , Stanley Chun-Wei Lee

This study identifies somatic DDX41 mutations as gain-of-function alleles that drive aberrant splicing, particularly of SEPTIN7, contributing to MDS/AML pathogenesis.

bioRxiv · Sep 24, 2026 · PreprintCancer Biology